Operating since 2011
More than 2.1M patients treated
The Wegovy pill is semaglutide in tablet form, taken once a day instead of being injected once a week.
The MHRA approved it on 11 June 2026, making it the first GLP-1 weight loss tablet licensed in the UK.
In its main trial, the Wegovy pill produced an average weight loss of 13.6% over 64 weeks, which is close to what the 2.4mg Wegovy injection produces.
The trade-off is a stricter daily routine: The pill has to be taken on an empty stomach, with a small sip of water, and nothing else for at least 30 minutes afterwards.
If needles are the reason you've held back from starting a weight loss treatment, this is probably the update you've been waiting for.
It's also worth knowing what the Wegovy pill is and isn't.
It isn't a milder or gentler version of the medication.
It's the same drug, at a dose designed to give roughly the same effect in your bloodstream.
The side effects are much the same, too.
But, here’s what changes.
No weekly injection, no refrigeration, no ice packs, no sharps bin.
Instead, a small pill first thing in the morning and a 30-minute-wait before your first cup of tea.
Curious? This guide outlines all you need to know the Wegovy pill, including what it is, how much weight does it help to lose, how to take it, dose schedule, side effects, and more.
Before you begin: A little bit about OnlineClinic
OnlineClinic has been operating since 2011 and has treated more than 2.1 million patients.
The pharmacy is registered with the General Pharmaceutical Council (GPhC), our prescribers are registered with the General Medical Council (GMC), and the service is regulated by the Care Quality Commission (CQC).
As of August 2026, on Trustpilot, the service rating is 4.6 out of 5 based on 6,643 reviews.
The MHRA authorised Wegovy 25mg tablets on 11 June 2026.
The UK was the first country in Europe to license an oral GLP-1 for weight management.
Three things follow from that:
Did you know
Semaglutide has existed as a tablet in the UK for years, sold as Rybelsus.
But Rybelsus is licensed only for type 2 diabetes, at much lower doses (3mg, 7mg, and 14mg).
It is not licensed for weight loss, so our prescribers will not issue it for that purpose.
If you want semaglutide in tablet form for weight management, the licensed product is the Wegovy pill.
We take the same position on Ozempic, and we explain why in Mounjaro vs Ozempic.
It's semaglutide, the same active ingredient as the Wegovy injection, pressed into a small pill.
Semaglutide mimics a gut hormone called GLP-1, which your body releases after you eat.
That hormone signals your brain to eat less and slows how quickly your stomach empties.
The practical result is that you feel full sooner, stay full longer, and think about food less.
Getting a molecule like semaglutide to survive the stomach is the hard part, and that’s why the pill took so long to arrive.
To solve this problem, Novo Nordisk combined semaglutide with an absorption helper called salcaprozate sodium, usually shortened to SNAC.
The SNAC protects semaglutide from stomach acid long enough for it to cross the stomach lining and get into the bloodstream.
Absorption happens in the stomach, and it only works well when the stomach is empty.
Food, drink, or other tablets sitting in there at the same time get in the way.
Here's the good part
Because absorption doesn't depend on temperature, the tablets don't need refrigeration.
They can be stored in their blister pack at normal room temperature, away from direct sunlight, with a three-year shelf life.
While the Wegovy pill and the Wegovy injection contain the same active ingredient, their mechanism of action and weight loss results are quite different.
Here’s a head-to-head comparison between the pill and the injection, so that you can choose your option wisely.
| Wegovy tablet | Wegovy injection | |
|---|---|---|
| Active ingredient | Semaglutide | Semaglutide |
| How often | Once a day | Once a week |
| How it's taken | Swallowed whole on an empty stomach first thing in the morning | Injected under the skin |
| Dose range | 1.5mg, 4mg, 9mg, 25mg | 0.25mg, 0.5mg, 1mg, 1.7mg, 2.4mg, 7.2mg |
| Timing rules | Fast 8 hours before, wait 30 minutes after | None, take it with or without food |
| Average weight loss in trials | 13.6% at 64 weeks on 25mg (OASIS 4) | 14.9% at 68 weeks on 2.4mg (STEP 1) |
| Storage | Room temperature, keep in blister pack | Refrigerate before first use. Can keep at room temperature afterwards. |
| Needles and sharps bin | Not needed | Needed |
| Licensed for heart risk reduction | No | Yes, the 2.4mg dose |
| Under additional MHRA monitoring | Yes | Yes |
If you’re considering semaglutide for reducing the risk of a further heart attack or stroke, the 2.4mg injection is the product with that specific UK licence and NICE recommendation behind it.
We cover that in detail in Wegovy and heart health.
On 10 August 2026, the MHRA authorised a second weight loss tablet, orforglipron, sold as Foundayo, manufactured by Eli Lilly.
The UK is the first country in Europe to approve this pill
So in the space of two months, the UK has gone from zero licensed weight loss pills to approving two of them.
Semaglutide is a peptide that the stomach acid breaks down, which is why the Wegovy tablet needs the SNAC absorption helper and all the fasting rules that go with it.
Orforglipron is a small molecule, so it survives digestion on its own.
This means there’s no eight-hour fast, no water limit, no thirty-minute wait, and no fixed time of day to take this pill. You take it when you like, with food or without.
| Wegovy tablet | Foundayo | |
|---|---|---|
| Active ingredient | Semaglutide | Orforglipron |
| Made by | Novo Nordisk | Eli Lilly |
| MHRA approval | 11 June 2026 | 10 August 2026 |
| Timing rules | 8-hour fast, sip of water, 30-minute wait | None at all |
| Average weight loss in main trial | 13.6% at 64 weeks on 25mg (OASIS 4) | 11.2% at 72 weeks on 36mg (ATTAIN-1) |
| Also licensed for type 2 diabetes | No | Yes |
| Available in the UK today | Yes | Approved, but not yet on sale |
In the trial for the Wegovy pill, called the OASIS 4, followed 307 adults with obesity, or with overweight plus a weight-related condition for 64 weeks.
Every participant also followed a well-balanced diet and performed adequate physical activity.
Average weight loss at 64 weeks:
Average waist circumference fell by 12.2cm, and 26% of participants finished the trial with a BMI below 30.
Among those who started with prediabetes, 71.1% of participants taking the Wegovy pill had normal blood glucose by the end, compared with 33.3% of participants taking a placebo.
For context, the 2.4mg Wegovy injection produced 14.9% average weight loss over 68 weeks in the STEP 1 trial.
The pill lands in similar territory.
The higher-strength 7.2mg injection and Mounjaro both produce larger average losses, and we compare all of them in Mounjaro vs Wegovy.
One honest caveat about the evidence.
OASIS 4 was a relatively small trial, with 307 people, and the participants were mostly women and mostly white.
It also had no head-to-head comparison against the injection, so any pill-versus-injection comparison is drawn across separate trials rather than measured directly.
Here is how you need to take the once-daily Wegovy pill:
Quick tip
The 30-minute wait is the bit people find hardest, mostly because it collides with the morning cup of tea.
The practical fix is to keep the blister pack on the bedside table, take the pill before getting up, and take a shower and dress up in the next 30 minutes.
By the time they are in the kitchen, the 30 minutes would have passed.
If you miss a dose, skip that dose completely and take your next one at the usual time the following morning.
Don't double up to make up for the missed dose.
The Wegovy pill comes in four doses: 1.5mg, 4mg, 9mg, and 25mg.
Each dose lasts for at least four weeks before the next increase.
The dose escalation is gradual to allow your body to adjust to a new dose and its side effects in a comfortable manner.
Here is the entire Wegovy pill dosage schedule:
The starting dose. Low on purpose to let your gut get used to the medicine.
The first dose increase. Side effects tend to reappear briefly around each increase, then settle gradually.
Most people notice a reduction in appetite and weight loss at this dose.
The maintenance dose, and the one that the trial results are based on.
Your prescriber may ask you to continue on this dose for a long term if you’ve lost sufficient weight by this point and you’re able to tolerate this dose well.
If you're already on the 2.4mg weekly injection, the switch is more straightforward than you might assume.
The product licence allows patients on 2.4mg weekly injections to move straight onto 25mg pill, with no need to start again from scratch.
You take your first tablet one week after your last injection, on the day the next injection would have been due.
Two things to keep in mind:
You can start a switch from Wegovy injection to Wegovy pill through your OnlineClinic account, and a GMC-registered prescriber will review whether it's appropriate for you before anything is dispensed.
Like any other GLP-1 medicines, most side effects are gastrointestinal in nature.
Most of the side effects are at their peak around the dose increases, and they settle gradually.
If you want to learn more about Wegovy injection’s side effects, check out our guide on Wegovy side effects week by week.
Here's what was reported over 64 weeks in the OASIS 4 trial.
Indigestion turned up more often with the pill than it does with the injection.
When to stop and get help urgently
Some symptoms need same-day attention rather than a wait-and-see approach. Stop taking the Wegovy pill and get immediate help if you experience:
If you're having any procedure under general anaesthetic or deep sedation, including dental work, tell the team you're taking semaglutide.
Because the medicine slows stomach emptying, food can still be present when the anaesthetist expects an empty stomach.
Any side effect you suspect can be reported through the MHRA Yellow Card scheme, and doing so genuinely helps.
You might not be eligible to take the Wegovy pill if you:
Speak to a provider if any of this applies to you:
If you could become pregnant, you'll be advised to use contraception while on treatment.
Semaglutide doesn't appear to interfere with the combined pill's absorption in the way tirzepatide can, and we cover this in detail in Mounjaro and contraception.
Because the pill needs an empty stomach to absorb well and it slows digestion, it interacts with other oral medicines more than the injection does.
Tell your prescriber about every medicine you take, including anything bought over the counter.
This includes:
Reassuringly, no meaningful interaction was found with metformin, digoxin, furosemide, omeprazole, or combined oral contraceptives.
Our Wegovy tablet prices start at £69.99 per month.
Every price includes the consultation, the prescription, the pharmacy dispensing fee, packaging, and delivery. There are no hidden fees and nothing to pay for treatment that isn't issued.
Because the tablet doesn't need cold packaging, there's no temperature-controlled shipping cost built into it either.
There's no single right answer when it comes to choosing the right medicine and form for your weight loss treatment, and your prescriber's view of your medical history matters more than any general rule.
That said, the practical picture usually looks like this.
You can compare the full picture in our guide to Mounjaro vs Wegovy and the Wegovy dosage schedule explained.
Our process is straightforward. From start to finish, this is what happens when you order with us:
Our Wegovy prices start at £69.99 for both the pill and the injection, and every price includes the prescription, the consultation, the packaging, and delivery. There are no hidden fees.
We prescribe Wegovy pill for weight management following an online consultation.
Operating since 2011
More than 2.1M patients treated
CQC · GPhC · GMC regulated
Trustpilot 4.6 / 5 from 6,643+ reviews
Disclaimer
Wegovy pills are a prescription-only medicine. Whether the treatment is suitable for you is a decision made by a GMC-registered prescriber based on your individual medical history. The information here is general guidance and is not a substitute for professional medical advice.
Reviewed by Dr. Anup Jethwa
Reviewed by Dr. Anup Jethwa
Reviewed by Dr. Anup Jethwa
Reviewed by Dr. Anup Jethwa
Reviewed by Dr. Anup Jethwa
Reviewed by Dr. Anup Jethwa
Reviewed by Dr. Anup Jethwa